Geneva Capital Management LLC Lowers Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Geneva Capital Management LLC decreased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 1.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 189,013 shares of the medical instruments supplier's stock after selling 2,963 shares during the quarter. Geneva Capital Management LLC owned about 3.48% of Mesa Laboratories worth $24,925,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of MLAB. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Mesa Laboratories by 20.3% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 10,103 shares of the medical instruments supplier's stock valued at $1,312,000 after purchasing an additional 1,708 shares in the last quarter. Barclays PLC grew its position in Mesa Laboratories by 357.4% during the third quarter. Barclays PLC now owns 8,837 shares of the medical instruments supplier's stock worth $1,148,000 after buying an additional 6,905 shares during the period. Geode Capital Management LLC grew its position in Mesa Laboratories by 4.8% during the third quarter. Geode Capital Management LLC now owns 124,761 shares of the medical instruments supplier's stock worth $16,205,000 after buying an additional 5,771 shares during the period. Victory Capital Management Inc. lifted its position in shares of Mesa Laboratories by 90.3% during the 3rd quarter. Victory Capital Management Inc. now owns 14,001 shares of the medical instruments supplier's stock valued at $1,818,000 after acquiring an additional 6,643 shares during the period. Finally, Franklin Resources Inc. boosted its stake in shares of Mesa Laboratories by 27.8% during the 3rd quarter. Franklin Resources Inc. now owns 6,444 shares of the medical instruments supplier's stock worth $828,000 after acquiring an additional 1,403 shares in the last quarter. Institutional investors and hedge funds own 90.60% of the company's stock.

Remove Ads

Mesa Laboratories Price Performance

NASDAQ MLAB traded down $11.87 during trading hours on Monday, reaching $125.67. The company's stock had a trading volume of 29,123 shares, compared to its average volume of 35,307. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. The company's 50-day moving average is $140.26 and its two-hundred day moving average is $129.72. Mesa Laboratories, Inc. has a fifty-two week low of $83.68 and a fifty-two week high of $155.12. The stock has a market cap of $682.89 million, a PE ratio of -2.72 and a beta of 0.82.

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, beating the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. Analysts forecast that Mesa Laboratories, Inc. will post 8 EPS for the current year.

Mesa Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, February 28th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.51%. The ex-dividend date is Friday, February 28th. Mesa Laboratories's payout ratio is -1.38%.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded Mesa Laboratories from a "buy" rating to a "hold" rating in a research note on Wednesday, November 13th.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.